CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Common Equity of $2.95 million for the quarter ended Jun 30, 2026, down 76.4% from $12.51 million a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Common Equity (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, CollPlant Biotechnologies' Common Equity came in at $6.08 million, down 54.8% from the prior year.
- Annual Common Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 6.3% (years ended Dec 2020 to Dec 2025).
- In prior years, CollPlant Biotechnologies' Common Equity was $13.47 million in the year ended Dec 31, 2024 (-52.5%), $28.34 million in the year ended Dec 31, 2023 (-12.2%), $32.28 million in the year ended Dec 31, 2022 (-28.5%) and $45.12 million in the year ended Dec 31, 2021 (+907.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Common Equity since the quarter ended Jun 30, 2019.
- The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Dec 31, 2021, with growth of 907.8%; the weakest was the quarter ended Jun 30, 2026, with a decline of 76.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.25 Bn | 1,104.84 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 615.56 Bn | 534.09 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 506.32 Bn | 479.44 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.72 Bn | 322.10 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.15 Bn | 262.14 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 262.32 Bn | 236.01 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.40 Bn | 191.80 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.30 Bn | 165.50 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.97 Bn | 117.62 Bn | 10.94 Bn | 85.49 Bn |
| 10 | CollPlant Biotechnologies | 4.43 Mn | -17.93 Mn | -456,000.00 | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.95 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 12.51 Mn |
| Mar 31, 2025 | 12.40 Mn |
| Dec 31, 2024 | 13.47 Mn |
| Sep 30, 2024 | 16.92 Mn |
| Jun 30, 2024 | 20.73 Mn |
| Mar 31, 2024 | 24.45 Mn |
| Dec 31, 2023 | 28.34 Mn |
| Sep 30, 2023 | 32.40 Mn |
| Jun 30, 2023 | 36.04 Mn |
| Mar 31, 2023 | 29.89 Mn |
| Dec 31, 2022 | 32.28 Mn |
| Sep 30, 2022 | 35.81 Mn |
| Jun 30, 2022 | 39.51 Mn |
| Mar 31, 2022 | 43.20 Mn |
| Dec 31, 2021 | 45.12 Mn |
| Sep 30, 2021 | 48.48 Mn |
API Access
CollPlant Biotechnologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();